Cytokinetics had a nice pop today and is currently up 7.33% -- which is pretty good. Investors have a more positive outlook for the company and future revenue.
The Biotechnology company isn't at an immediate support or resistance level that might be predictive. Cytokinetics hasn't shown a lot of strength recently, shareholders don't seem that energized about the Biotechnology company's future prospects. It might slide down to the $42.5 level and find some buyers to give it support.
The analysts are pretty neutral on Cytokinetics right now, so not much useful information here. The current Analysts Sentiment Score is 4.83. Most companies range between (-200 to 200).
Here's a break down of the latest rating changes. Oppenheimer reiterated a rating of Outperform on 2024-03-04 and added a price target of $107.00. Needham & Company LLC announced that they are reiterating a rating of Buy on 2024-02-28 and they set their price target at $108.00. On 2024-02-28 HC Wainwright reiterated their rating of Buy and added a price target of $94.00. UBS Group downgraded from Buy to Neutral on 2024-01-24 but also increased their price target by 50.82% to $92.00. Mizuho gave a boost to their price target and moved to $103.00 from $80.00 on 2024-01-22. On 2024-01-05 Morgan Stanley reiterated their rating of Overweight and moved up their price target to $90.00 which is a 50% increase. Raymond James gave a boost to their price target and moved to $92.00 from $63.00 on 2023-12-28. Truist Financial decided to move up their price target on 2023-12-28 to $86.00 which is a 43.33% increase. The Goldman Sachs Group initiated a rating of Buy on 2023-11-09 and provided a price target of $50.00. On 2023-11-07 B. Riley initiated their coverage and rated as Buy and added a price target of $66.00.
| Company | Ratings Score
?
Composite analyst sentiment score
|
Positive Ratings | Negative Ratings | Boost Price Target | Lower Price Target |
|---|---|---|---|---|---|
| CYTK | 4.83 | 4.84 | -1.41 | 6.68 | -0.45 |
| Company | YOY Growth Score (typical -20 to +20) | Revision Directions (-6 to +6) |
|---|---|---|
| CYTK | 0.00 | 0.00 |
We take into account several different measures of short interest to create a composite score. These measures are shown in the chart below. Short selling is when investors are betting against a stock. We compile these factors to create a dynamic Short Score - this can indicate poor sentiment, internal problems with a company or industry and the anticipation of future price declines. We look at the short interest percent, days to cover, the rate of change and total shares sold short.
| Company | Short Score (typical 1-15)
?
We take into account several different measures and attributes of short interest to create a composite sentiment score. typical range (0 - 30)
|
Short Interest | Days to Cover | Rate of Change | Shares Short |
|---|---|---|---|---|---|
| CYTK | 11.73 | %11.1 | 11.3 | 8.778 | 9950000 |
| Segment | Count | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest | Analysts Ratings ? |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Biotechnology | 88 | 2.38 | -5.16 | -7.72 | -9.62 | -10.21 | -0.27 | 38.48 | -21.91 | -14.89 | -10.45 | -20474.55 | -17382.76 | 6.82 | 7.39 | 9.22 | 2.00 |
| Healthcare | 221 | 1.83 | -2.17 | -4.06 | -6.43 | -7.06 | 0.60 | 42.13 | 7.10 | -10.38 | -6.71 | -21013.92 | -12401.53 | 9.73 | 4.41 | 6.59 | 1.26 |
Social Sentiment is an aggregation of several different factors such as news, articles, blogs, user content, ratings, etc. Which is shown in the chart below. It may become predictive of a reversal if price and the sentiment diverge. Broader market forces may push prices up or down but if market participants maintain a different view on a specific stock, it may be taken as an opportunity to buy or sell in those cases.
| Ticker | Social Sentiment(1-10) |
|---|---|
| CYTK |
| Company | Score | 1 Day% | 5 Day | 1 Month | 3 Month | 6 Month | 1 Year | RSI | 3mo S-momo ? | 6mo S-momo | 1yr S-momo | Resistance ? | Support | Demark Sell ? | Demark Buy | Short Interest Score |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DNLI | Denali Therapeutics Inc. | 0.74 | 11.80 | -3.24 | -15.55 | -30.68 | -52.08 | -29.10 | 42 | -44.67 | -44.39 | -23.95 | -34122.65 | 0.00 | 0 | 0 | 11.2371 |
| ARWR | Arrowhead Research Corpor | 0.57 | 3.97 | -8.04 | -28.18 | -34.92 | -33.84 | -51.55 | 26 | -42.80 | -30.90 | -42.63 | -51091.94 | 0.00 | 0 | 0 | 7.83995 |
| RCKT | Rocket Pharmaceuticals, I | 0.57 | 8.43 | -20.05 | -29.92 | -48.99 | -63.20 | -75.49 | 29 | -243.06 | -236.61 | -258.07 | -57719.96 | 0.00 | 0 | 0 | 9.12889 |
| NTLA | Intellia Therapeutics, In | 0.56 | 9.69 | -13.10 | -26.26 | -42.97 | -61.98 | -70.92 | 28 | -120.81 | -146.54 | -160.07 | -79794.15 | 0.00 | 0 | 0 | 10.4627 |
| SAGE | Sage Therapeutics, Inc | 0.54 | -1.15 | -10.28 | 2.51 | 24.92 | 11.64 | -54.96 | 75 | -1.05 | -0.91 | -5.10 | 163.55 | -7055.63 | 150 | 0 | 12.6533 |
| ZS | Zscaler, Inc. Common Stoc | 0.54 | 2.97 | -1.15 | 2.41 | 9.71 | 23.98 | 9.70 | 60 | 18.37 | 19.55 | 19.85 | -1070.06 | -7519.91 | 125 | 0 | 4.2908 |
How to use: use the research links to research the asset. Then simply type in a score for each category between (01, 02, 03, 04, 05). 05 being the most bullish and 01 being the most bearish. It will automatically calculate the average and combine it with the technical score to create an overall score to rank prospects by. You can also type notes into each field.
